BROADCASTS.com

b'S2E33: The End of Trial and Error Treatments with Nick Glimcher, CEO at Blue Genes Lab and host Dr. Nick. As you will hear, the genome brings a whole new data set and useful information into the healthcare setting. Unlike before, there are ways to incorporate this into the clinical setting by integrating the data and bringing real-time data and insights to a patient consultation. As the data continues to expand, along with the science and understanding we must rely on integration and automation to bring the best of science to the clinical workplace. Your better pill to swallow is to work to incorporate genomic testing, results, and decision-making into your clinical workflow. While testing does incur additional costs the downstream positive impact is clear, especially given the frequency of complications from selecting the wrong therapy. Patients need and want the right therapy the first time, the doctors want to give that, and the payers want the costs to be for therapy that brings benefit to the patient. We can deliver this and do so economically. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to \\u201c\\u2026.Play Healthcare NOW Radio\\u201d. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen'